BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 10130385)

  • 21. Assessing the clinical impact of pharmacists' interventions.
    Brown G
    Am J Hosp Pharm; 1991 Dec; 48(12):2644-7. PubMed ID: 1814210
    [No Abstract]   [Full Text] [Related]  

  • 22. Formalizing written communication by decentralized pharmacists with prescribers.
    Heitman D; Krivanek F
    Hosp Pharm; 1994 Dec; 29(12):1078, 1080, 1082-3. PubMed ID: 10138835
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of two systems for documenting pharmacist interventions in patient care.
    Schumock GT; Hutchinson RA; Bilek BA
    Am J Hosp Pharm; 1992 Sep; 49(9):2211-4. PubMed ID: 1524064
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Applying total quality management to a pharmacist intervention program.
    Sanborn MD; Braman K; Herriott K
    Top Hosp Pharm Manage; 1993 Jul; 13(2):62-7. PubMed ID: 10128816
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assuring the quality of a clinical pharmacokinetics service.
    Waller DJ; Smith SR
    Am J Hosp Pharm; 1986 Sep; 43(9):2184-8. PubMed ID: 3766569
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quality and outcome: pharmacy's professional imperative.
    Enright SM; Flagstad MS
    Am J Hosp Pharm; 1991 Sep; 48(9):1908-11. PubMed ID: 1928131
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overestimating clinical functions of distributive staff pharmacists.
    Dillon KR; Caselnova DA
    Hosp Pharm; 1989 Oct; 24(10):849-52. PubMed ID: 10295901
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Documentation of pharmacist interventions in a decentralized unit dose system.
    Hoolihan RJ; Skoogman LH
    Hosp Pharm; 1991 Oct; 26(10):875-9. PubMed ID: 10114008
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comprehensive clinical pharmacy documentation in an out-patient cancer facility.
    Davies NM; Spaven JR; Chambers CR
    Can J Hosp Pharm; 1992 Jun; 45(3):107-11. PubMed ID: 10119690
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hospital mainframe computer documentation of pharmacist interventions.
    Schumock GT; Guenette AJ; Clark T; McBride JM
    Top Hosp Pharm Manage; 1993 Jul; 13(2):16-24. PubMed ID: 10128811
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Six Sigma: not for the faint of heart.
    Benedetto AR
    Radiol Manage; 2003; 25(2):40-53. PubMed ID: 12800564
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quality assurance program for a nuclear pharmacy.
    Hiltz A; Pierce S
    Can J Hosp Pharm; 1991 Feb; 44(1):25-9. PubMed ID: 10110040
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multidisciplinary program for detecting and evaluating adverse drug reactions.
    Keith MR; Bellanger-McCleery RA; Fuchs JE
    Am J Hosp Pharm; 1989 Sep; 46(9):1809-12. PubMed ID: 2801715
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A simplistic approach to establishing drug usage/quality assurance programs.
    Adachi W
    Hosp Pharm; 1990 Jun; 25(6):541-4, 546-50, 555-9. PubMed ID: 10104830
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical career ladders: the Washington Hospital Center.
    Barbaccia JG; Mowrey D
    Am J Hosp Pharm; 1989 Nov; 46(11):2276-9. PubMed ID: 2589342
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quality assurance program for a hospital investigational-drug service.
    Tankanow RM; Savitsky ME; Volger BW; Ryan ML; Colvin CL
    Am J Hosp Pharm; 1989 May; 46(5):962-9. PubMed ID: 2729303
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quality assurance and certification program for an aminoglycoside monitoring service.
    Shevchuk YM; Poulin S
    Can J Hosp Pharm; 1990 Apr; 43(2):49-55. PubMed ID: 10106632
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of competency standards for quality assurance in clinical pharmacokinetics.
    Burkle WS; Matzke GR; Lucarotti RL
    Hosp Pharm; 1980 Oct; 15(10):494-6. PubMed ID: 10249052
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The integration of quality assessment and a patient-specific intervention/outcomes program.
    Mutnick AH; Sterba KJ; Szymusiak-Mutnick BA
    Pharm Pract Manag Q; 1998 Jan; 17(4):25-36. PubMed ID: 10174746
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Designing drug-usage evaluation to meet Joint Commission requirements.
    Peroutka JA
    Pharm Pract Manag Q; 1996 Jul; 16(2):26-35. PubMed ID: 10161608
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.